Not applicableAvailableNCT04853602
What this trial is testing
IFx-Hu2.0 Expanded Access Program
Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IVMerkel Cell Carcinoma+1 more
TuHURA Biosciences, Inc.
Showing 20 of 0 results